The structure of Dextropropoxyphene
Find information on thousands of medical conditions and prescription drugs.

Dextropropoxyphene

Dextropropoxyphene is an analgesic in the opioid category. It is used to treat mild to moderate pain and as an antitussive. It can be used to ease pain before, during and after an operation. It is often combined with acetominophen in the preparation co-proxamol(Darvocet in the US). more...

Home
Diseases
Medicines
A
B
C
D
Dacarbazine
Dactinomycin
Dalmane
Danazol
Dantrolene
Dapoxetine
Dapsone
Daptomycin
Daraprim
Darvocet
Darvon
Daunorubicin
Daunorubicin
Daypro
DDAVP
Deca-Durabolin
Deferoxamine
Delsym
Demeclocycline
Demeclocycline
Demerol
Demulen
Denatonium
Depakene
Depakote
Depo-Provera
Desferal
Desflurane
Desipramine
Desmopressin
Desogen
Desogestrel
Desonide
Desoxyn
Desyrel
Detrol
Dexacort
Dexamethasone
Dexamfetamine
Dexedrine
Dexpanthenol
Dextran
Dextromethorphan
Dextromoramide
Dextropropoxyphene
Dextrorphan
Diabeta
Diacerein
Diacetolol
Dial
Diamox
Diazepam
Diazoxide
Dibenzepin
Diclofenac
Diclohexal
Didanosine
Dieldrin
Diethylcarbamazine
Diethylstilbestrol
Diethyltoluamide
Differin
Diflucan
Diflunisal
Digitoxin
Digoxin
Dihydrocodeine
Dihydroergotamine
Dihydrotachysterol
Dilantin
Dilaudid
Diltahexal
Diltiazem
Dimenhydrinate
Dimercaprol
Dimetapp
Dimethyl sulfoxide
Dimethyltryptamine
Dimetridazole
Diminazene
Diovan
Dioxybenzone
Diphenhydramine
Diphenoxylate
Dipipanone
Dipivefrine
Diprivan
Diprolene
Diproteverine
Dipyridamole
Disulfiram
Disulfiram
Dizocilpine
Dobutamine
Docetaxel
Docusate sodium
Dofetilide
Dolasetron
Dolobid
Dolophine
Domperidone
Donepezil
Dopamine
Dopram
Doral
Doramectin
Doriden
Dornase alfa
Doryx
Dostinex
Doxapram
Doxazosin
Doxepin
Doxil
Doxil
Doxorubicin
Doxy
Doxycycline
Doxyhexal
Doxylamine
Drisdol
Drixoral
Dronabinol
Droperidol
Drospirenone
Duloxetine
Durabolin
Duragesic
Duraphyl
Duraquin
Dutasteride
Dv
Dyclonine
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z

It is an optical isomer of Levopropoxyphene. The racemic mixture is called Propoxyphene.

Some preparations that contain dextropoxyphene include: Distalgesic and Doloxene.

The therapeutic index of dextropoxyphene is relatively small. In the UK, dextropoxyphene and co-proxamol are now discouraged from general use. Since 2004 preparations containing only dextropropoxyphene have been discontinued.

In the United States, dextropropoxyphene HCl is available as a prescription with acetaminophen in ratio anywhere from 30mg / 600mg to 60mg / 325mg, respectively. These are usually named "Darvocet," "Darvin," or "Darvon." Dextropropoxyphene is subject to some controversy: while many physicians prescribe it for a wide range of mildly to moderately painful symptoms as well as in treatment of diarrhoea, many others refuse to prescribe it, citing its highly addictive nature and limited effectiveness (some studies show it to be no more effective as a painkiller than aspirin).

Darvocet overdose is commonly broken into two categories: acetaminophen toxicity and dextropropoxyphene overdose. Many users experience toxic effects from the acetaminophen in pursuit of the endlessly-increasing dose required to achieve euphoria. They suffer acute liver toxicity, which causes severe stomach pain, nausea, and vomiting (all of which are increased by light or stimulation of the sense of sight).

Other users experience longer-term problems from consistent use of abusively high dextropropoxyphene levels. They take anywhere from 240 to 420 milligrams of dextropropoxyphene (and the acetaminophen that goes with it) in search of an increasingly elusive feeling of euphoria. These users often suffer a constantly dry mouth, decreased appetite, urinary retention and constipation. Because tolerance to dextropropoxyphene increases so quickly and because of its strong constipating effects, many people suffer a gruesome and painful rupture in the colon.


Read more at Wikipedia.org


[List your site here Free!]


The influence of caffeine on pain
From Townsend Letter for Doctors and Patients, 1/1/05 by Melvyn R. Werbach

The primary application of caffeine supplementation in pain control has been as an analgesic adjuvant when combined with certain analgesic drugs. This practice is supported by a number of double-blind studies. One of these studies found the potentiating action of caffeine on acetaminophen-induced pain relief to be similar to that experienced when an analgesic with a peripheral action (such as acetaminophen) is combined with another with a central action, in this case dextroproxyphen. By combining the peripherally-acting analgesic with caffeine instead of a centrally-acting analgesic, the side effects of central analgesics (such as drowsiness, constipation and nausea) can be avoided. (1)

[ILLUSTRATION OMITTED]

In a review of 30 clinical trials involving over 10,000 patients, the authors concluded that 40% higher dosages of aspirin, acetaminophen or salicylamide would be needed if they were not given in combination with a small dose of caffeine. (2) A similar adjuvant effect was found when caffeine was added to propyphenazone, (3) or to ibuprofen, a non-steroidal anti-inflammatory drug. (4) However, two recent meta-analyses of randomized controlled trials have questioned the efficacy of caffeine as an adjuvant as they found that caffeine added little to the analgesic effect of acetaminophen, (5) and was ineffective in enhancing the analgesic effect of aspirin. (6)

Studies have also investigated the efficacy of caffeine intake by itself, in treating acute pain. In a double-blind crossover study of 53 patients with non-migrainous headaches, subjects received 2 doses of caffeine, acetaminophen, 2 combinations of caffeine with acetaminophen, and placebo. Caffeine appeared to have an independent analgesic effect that remained significant when statistical adjustments were made for prior caffeine consumption and caffeine's effects on mood. Sixty-five milligrams of caffeine was just as effective as 648 milligrams of acetaminophen in relieving non-migrainous headache symptoms. (7)

However, when data on 131 patients with chronic back pain were reviewed, there were no significant differences between low, moderate and high caffeine users on subjective measures of pain severity or affective distress, (8) suggesting that chronic caffeine intake may be ineffective as a pain reliever.

Laboratory studies have investigated the mechanism by which caffeine may reduce pain. In vitro, instant coffee powders were shown to compete with naloxone for binding to opiate receptors. (9) This finding was not confirmed in vivo, however, as an animal study found that high doses of coffee, whether or not they contained caffeine, failed to show opiate-antagonizing activity. (10) More recent animal work has provided evidence suggesting that the antinociceptive effect of caffeine is mediated instead by central amplification of cholinergic transmission. (11) Moreover, adenosine is suspected to be the metabolite responsible for ischemic muscle pain, and caffeine is an adenosine receptor antagonist. (12)

A Warning

Caffeine can also have negative effects on pain. Acute caffeine withdrawal can cause distress due to "somatic dysfunction." (A term common to osteopathic physicians, somatic dysfunction refers to "impaired or altered function of related components of the somatic (body framework) system: skeletal, arthrodial, and myofascial structures, and related vascular, lymphatic and neural elements." (13)) Subjects in one study regularly consumed 300 mg or more of caffeine a day (found in about 2 eight-ounce cups of coffee or 6 eight-ounce cups of tea) and then abstained from caffeine for 4 days. The number of somatic dysfunctions were found to increase significantly during caffeine withdrawal. Even by day 4, most of the subjects had not fully returned to baseline. (14)

Also, a double-blind crossover study has found that caffeine ingestion may reduce the effectiveness of transcutaneous electrical nerve stimulation (TENS). (15) This finding suggests that patients trying TENS should avoid caffeine for a few days prior to the trial.

More information on the influence of nutrition on pain associated with a variety of illnesses can be found in the second edition of Dr. Werbach's classic SourceBook, Nutritional Influences on Illness--and in his updated and expanded CD-ROM with the same title. A free brochure on his books is available from Third Line Press Inc., 4751 Viviana Drive, Tarzana, California 91356, USA. (Phone: 800-916-0076; 818-996-0076; Fax: 818-774-1575; e-mail: tlp@third-line.com; Internet: www.third-line.com.)

References

1. Kuntz D, Brossel R. [Analgesic effect and clinical tolerability of the combination of paracetamol 500 mg and caffeine 50 mg versus paracetamol 400 mg and dextropropoxyphene 30 mg in back pain.] Presse Med 25(25):1171-4, 1996 (in French)

2. Laska EM et al. Caffeine as an analgesic adjuvant. JAMA 251(13):1711-18, 1984

3. Kraetsch HG et al. Analgesic effects of propyphenazone in comparison to its combination with caffeine. Eur J Clin Pharmacol 49(5):377-82, 1996

4. Forbes JA et al. Effect of caffeine on ibuprofen analgesia in postoperative oral surgery pain. Clin Pharmacol Ther 49(6):674-84, 1991

5. Zhang WY, Li Wan Po A. Analgesic efficacy of paracetamol and its combination with codeine and caffeine in surgical pain--a meta-analysis. J Clin Pharm Ther 21(4):261-82, 1996

6. Zhang WY, Po AL. Do codeine and caffeine enhance the analgesic effect of aspirin?--A systematic overview. J Clin Pharm Ther 22(2):79-97, 1997

7. Ward N, Whitney C, Avery D, Dunner D. The analgesic effects of caffeine in headache. Pain 44(2):151-5, 1991

8. Currie SR et al. Caffeine and chronic low back pain. Clin J Pain 11(3):214-19, 1995

9. Boublik JH et al. Coffee contains potent receptor binding activity. Nature 301:246-8, 1983

10. Strubelt O et al. Failure of coffee to inhibit the pharmacodynamic activity of morphine in vivo. Experientia 42(1):35-7, 1986

11. Ghelardini C et al. Caffeine induces central cholinergic analgesia. Naunyn Schmiedebergs Arch Pharmacol 356(5):590-5, 1997

12. Myers DE et al. Hypoalgesic effect of caffeine in experimental ischemic muscle contraction pain. Headache 37(10):654-8, 1997

13. Glossary of Osteopathic Terminology. Glossary Review Committee, Educational Council on Osteopathic Principles of the American Association of Colleges of Osteopathic Medicine. Revised April 2002

14. Reeves RR et al. Somatic dysfunction increase during caffeine withdrawal. J Am Osteopath Assoc 97(8):454-6, 1997

15. Marchand S et al. Effects of caffeine on analgesia from transcutaneous electrical nerve stimulation. Letter. N Engl J Med 333(5):325-6, 1995

by Melvyn R. Werbach, MD

4751 Viviana Drive * Tarzana, California 91356 USA

Phone 818-996-0076 * Fax 818-774-1575

COPYRIGHT 2005 The Townsend Letter Group
COPYRIGHT 2005 Gale Group

Return to Dextropropoxyphene
Home Contact Resources Exchange Links ebay